Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Inventory (2022 - 2024)

Atara Biotherapeutics' Inventory history spans 3 years, with the latest figure at $10.7 million for Q4 2024.

  • For Q4 2024, Inventory rose 9.78% year-over-year to $10.7 million; the TTM value through Dec 2024 reached $10.7 million, up 9.78%, while the annual FY2024 figure was $10.7 million, 9.78% up from the prior year.
  • Inventory reached $10.7 million in Q4 2024 per ATRA's latest filing, down from $14.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $18.7 million in Q2 2024 to a low of $1.6 million in Q4 2022.
  • Average Inventory over 3 years is $10.1 million, with a median of $9.7 million recorded in 2023.
  • Peak YoY movement for Inventory: skyrocketed 511.98% in 2023, then grew 9.78% in 2024.
  • A 3-year view of Inventory shows it stood at $1.6 million in 2022, then surged by 511.98% to $9.7 million in 2023, then rose by 9.78% to $10.7 million in 2024.
  • Per Business Quant, the three most recent readings for ATRA's Inventory are $10.7 million (Q4 2024), $14.0 million (Q3 2024), and $18.7 million (Q2 2024).